Contingency management interventions are quite successful at initiating and maintaining clinically significant periods of abstinence. Typically, contingency management is delivered in conjunction with a psychosocial substance abuse treatment program. However, there has been scant attention directed towards how to maximally deliver the contingency management interventions as part of a larger treatment package. One issue that will be important is to determine what the optimal length of a contingency management intervention should be. This proposal describes an experimentally rigorous clinical trial designed to begin exploring this issue. Methamphetamine-dependent participants will be randomly assigned to one of four conditions: standard treatment (16 weeks of psychosocial treatment plus no contingency management), 1 month contingency management (16 weeks of psychosocial treatment with contingency management delivered during the first 4 weeks), 2 month contingency management (16 weeks of psychosocial treatment with contingency management delivered during the first 8 weeks), 4 month contingency management (16 weeks of psychosocial treatment with contingency management delivered during the entire 16 weeks). Data will be analyzed to determine if the different durations of contingency management produce different rates of initiation of abstinence or different patterns of maintenance of abstinence. Follow up data collection will be conducted for a one year period, starting at randomization, to determine if the different durations of contingency management inculcate longer periods of post-treatment abstinence or result in different patterns of relapse. The successful completion of the proposed project will serve several purposes. First, it will provide data that will be useful in determining what the optimal length of contingency management interventions should be. This will be useful as we begin to transfer the contingency management approaches into community-based treatment clinics. This may also help to contain the cost of delivering contingency management interventions if it is demonstrated that shorter durations of contingency management are as effective as longer durations. Secondly, the successful completion of the proposed research will provide additional information on the utility of treating methamphetamine dependence with contingency management. This is timely, given the burgeoning rates of methamphetamine abuse being reported.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA017084-04
Application #
7257189
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Mcnamara-Spitznas, Cecilia M
Project Start
2004-07-15
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2009-06-30
Support Year
4
Fiscal Year
2007
Total Cost
$254,993
Indirect Cost
Name
Friends Research Institute, Inc.
Department
Type
DUNS #
010095032
City
Baltimore
State
MD
Country
United States
Zip Code
21201
McPherson, Sterling; Orr, Michael; Lederhos, Crystal et al. (2018) Decreases in smoking during treatment for methamphetamine-use disorders: preliminary evidence. Behav Pharmacol 29:370-374
Roll, John M; Chudzynski, Joy; Cameron, Jennifer M et al. (2013) Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav 38:2455-62
Prendergast, Michael; Podus, Deborah; Finney, John et al. (2006) Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 101:1546-60
Roll, John M; Prendergast, Michael; Richardson, Kimberly et al. (2005) Identifying predictors of treatment outcome in a drug court program. Am J Drug Alcohol Abuse 31:641-56